Filing Flows › Charles River Laboratories International (CRL) › DSA revenue
Charles River Laboratories International (CRL) DSA revenue by quarter
Charles River Laboratories International's DSA revenue was $596M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $592M (Q4 2025) to $618M (Q2 2025).
| Quarter | DSA revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $596M | -2% | -0.7% |
| Q2 2026 | $607M | +2% | -2% |
| Q1 2026 | $597M | +0.9% | +0.7% |
| Q4 2025 | $592M | -2% | — |
| Q3 2025 | $601M | -3% | — |
| Q2 2025 | $618M | +4% | — |
| Q1 2025 | $593M | — | — |
Q3 2026 at a glance
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Questions
What is Charles River Laboratories International's DSA revenue?
Charles River Laboratories International's DSA revenue was $596M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Charles River Laboratories International's DSA revenue changed?
Over the last 7 quarters it ranged from $592M (Q4 2025) to $618M (Q2 2025).
Q3 2026 results → · How Charles River Laboratories International makes money →